Q: Where did you grow up?
Princeton, New Jersey
Q: Where did you go to college?
I went to Monmouth University in West Long Branch, New Jersey.
Month: November 2022
Partisan control of Congress for the final two years of President Biden’s term in office was still undecided this morning, two days after Tuesday’s midterm elections.
Major national news organizations say Republicans are favored to take control of the House,
…
Congressional Medicare advisers are moving toward recommending what they say is a better way to give extra Medicare funding to safety-net hospitals that disproportionately serve low-income and/or uninsured beneficiaries.
If Congress and the executive branch adopt the proposal, however, it
…
Pressure on Congress to clarify the 340B program is reaching unprecedented levels, health care attorneys at the Manatt law firm said during a webinar Wednesday on the future of the program.
Meanwhile, a new survey by the firm showed that
…
Arkansas’s unique 340B contract pharmacy law is about drug delivery, not drug pricing, and thus does not conflict with the federal 340B statute, Arkansas state officials and 340B providers said recently in the latest volley in the drug industry’s federal
…
National hospital groups, as expected, late last week asked a judge again to order the federal government to promptly repay 340B hospitals for illegally reduced Medicare Part B drug payments from 2018 through late September. They asked the first time
…
SPONSORED CONTENT
In this webinar session, we’ll teach CEs how to optimally manage your 340B data submission. You’ll learn about pulling TPA claims, submitting data, wholesaler price and pharmacy usage monitoring. We will discuss new developments regarding pharmacy usage vs. purchasing monitoring, and how to avoid being flagged—and risk losing 340B pricing.
We will cover:
- New developments in the industry and legal landscape
- Pitfalls to avoid when submitting to ESP
- Ordering best practices for maximizing 340B Catalog Pricing
- Features of the ESP site, including: monitoring uploads, usage, and purchasing patterns
Speakers will include:
Anthony Velasquez, Chief Product Officer, PharmaForce
… 
Drug manufacturers GlaxoSmithKline and Purdue Pharma have announced refunds for overcharging 340B covered entities, GSK for the fourth time and Purdue for the second time this year.
The U.S. Health Resources and Services Administration (HRSA) recently posted the companies’ notices
…
The federal government has had “more than adequate time to correct” its unlawful Medicare Part B payment cuts for hospitals’ 340B purchased drugs from 2018 through 2022 and should promptly reimburse the hospitals it harmed, the American Hospital Association said
…
There could be a loophole in Tuesday’s Medicare hospital outpatient payment final rule for 2023 that lets the government keep paying hospitals for 340B-acquired drugs at average sales price minus 22.5% at some hospital offsite locations, healthcare lawyers said yesterday.
…
×
*Sign up for news summaries and alerts from 340B Report